Article Text

Download PDFPDF
Giant basal cell carcinoma: a clinical red flag
  1. Vishal Kaundal and
  2. Guruswamy Vishwanath
  1. Plastic Surgery, Dr D Y Patil Vidyapeeth University Dr D Y Patil Medical College Hospital and Research Centre, Pune, Maharashtra, India
  1. Correspondence to Dr Vishal Kaundal; vishal.kaundal87{at}gmail.com

Abstract

Giant basal cell carcinoma (GBCC) is a rare and more aggressive variant of basal cell carcinoma. We present a case of GBCC with an overview of the challenges it presents.

A man in his 60s presented to the tertiary care unit with a history of an ulcer over the posterior aspect of his left heel for the past 1 year. Examination revealed an ulceroproliferative lesion of 10×8 cm on the posterior aspect of the left heel and lower Tendo-Achilles region. A wedge biopsy of the lesion was performed twice, which demonstrated basal cell carcinoma. The patient underwent excision of the lesion with 10 mm margins. A split-thickness skin graft was placed and secured over the resultant wound with the application of a negative pressure wound dressing.

The correlation between tumour size and tumour behaviour is examined. Additionally, the significance of tumour location, width of margins, incidence recurrence or metastasis is also studied.

  • Surgery
  • Plastic and reconstructive surgery

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors The following authors were responsible for drafting the text, sourcing and editing of clinical images, investigation results, drawing original diagrams and algorithms, and critical revision for important intellectual content: VK and GV. The following author gave final approval of the manuscript: GV.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.